Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
N-Boc 3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine acts as a reagent for the preparation of pyrimidinylaminobenzamides as inhibitors of tyrosine kinases in particular tyrosine kinases for treatment of leukemia